(SHEL) Shell - Overview
Exchange: NYSE •
Country: United Kingdom •
Currency: USD •
Type: Common Stock •
ISIN: US7802593050
Stock:
Total Rating 54
Risk 73
Buy Signal -0.17
| Risk 5d forecast | |
|---|---|
| Volatility | 21.2% |
| Relative Tail Risk | 1.06% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.04 |
| Alpha | 21.35 |
| Character TTM | |
|---|---|
| Beta | 0.327 |
| Beta Downside | 1.456 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.47% |
| CAGR/Max DD | 0.82 |
EPS (Earnings per Share)
Revenue
Description: SHEL Shell
Shell plc operates as an energy and petrochemical company Europe, Asia, Oceania, Africa, the United States, and other Americas. It operates through Integrated Gas; Upstream; Marketing; Chemicals and Products; and Renewables and Energy Solutions segments. The company explores for and extracts natural gas to produce liquefied natural gas or convert into gas-to-liquids products; explores for and extracts crude oil and natural gas liquids; and operates upstream and midstream infrastructure to deliver gas to market. It is also involved in marketing supplies fuels and lubricants for transport, manufacturing, mining, power generation, agriculture, and construction industries; operates electric vehicle charging and convenience retail; turn crude oil and other feedstocks into products for households, industry, and transport; trades crude oil, oil products, and petrochemicals; and oil sand activities. In addition, the company generates, markets, and trades power from wind, solar and pipeline gas; hydrogen production and marketing; commercial carbon capture and storage hubs; carbon credits and nature-based solutions; and provides heavy-duty LNG-fuelled trucks. Further, it offers base chemicals, including ethylene, propylene, and aromatics, as well as intermediate chemicals, such as styrene monomer, propylene oxide, solvents, linear alpha olefins, detergent alcohols, ethylene oxide, ethylene glycol, and polyethylene; and sustainable aviation fuel. The company was formerly known as Royal Dutch Shell plc and changed its name to Shell plc in January 2022. Shell plc was founded in 1897 and is headquartered in London, the United Kingdom.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 17.80b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -2.92 > 1.0 |
| NWC/Revenue: 9.29% < 20% (prev 11.57%; Δ -2.27% < -1%) |
| CFO/TA 0.11 > 3% & CFO 41.68b > Net Income 17.80b |
| Net Debt (74.36b) to EBITDA (54.69b): 1.36 < 3 |
| Current Ratio: 1.30 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.90b) vs 12m ago -6.67% < -2% |
| Gross Margin: 16.43% > 18% (prev 0.15%; Δ 1628 % > 0.5%) |
| Asset Turnover: 70.29% > 50% (prev 73.35%; Δ -3.06% > 0%) |
| Interest Coverage Ratio: 6.98 > 6 (EBITDA TTM 54.69b / Interest Expense TTM 4.66b) |
Altman Z'' 3.64
| A: 0.07 (Total Current Assets 107.17b - Total Current Liabilities 82.42b) / Total Assets 370.35b |
| B: 0.52 (Retained Earnings 190.83b / Total Assets 370.35b) |
| C: 0.09 (EBIT TTM 32.56b / Avg Total Assets 378.98b) |
| D: 0.90 (Book Value of Equity 175.09b / Total Liabilities 195.03b) |
| Altman-Z'' Score: 3.64 = AA |
Beneish M -2.70
| DSRI: 1.52 (Receivables 44.60b/31.23b, Revenue 266.38b/284.31b) |
| GMI: 0.94 (GM 16.43% / 15.49%) |
| AQI: 1.10 (AQ_t 0.21 / AQ_t-1 0.19) |
| SGI: 0.94 (Revenue 266.38b / 284.31b) |
| TATA: -0.06 (NI 17.80b - CFO 41.68b) / TA 370.35b) |
| Beneish M-Score: -2.70 (Cap -4..+1) = A |
What is the price of SHEL shares?
As of March 03, 2026, the stock is trading at USD 84.22 with a total of 9,566,767 shares traded.
Over the past week, the price has changed by +5.31%, over one month by +12.25%, over three months by +14.94% and over the past year by +31.81%.
Over the past week, the price has changed by +5.31%, over one month by +12.25%, over three months by +14.94% and over the past year by +31.81%.
Is SHEL a buy, sell or hold?
Shell has received a consensus analysts rating of 4.41.
Therefore, it is recommended to buy SHEL.
- StrongBuy: 9
- Buy: 6
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SHEL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 82.8 | -1.7% |
| Analysts Target Price | 82.8 | -1.7% |
SHEL Fundamental Data Overview February 28, 2026
P/E Trailing = 13.53
P/E Forward = 10.7875
P/S = 0.8602
P/B = 1.1445
P/EG = 1.6278
Revenue TTM = 266.38b USD
EBIT TTM = 32.56b USD
EBITDA TTM = 54.69b USD
Long Term Debt = 95.45b USD (estimated: total debt 104.58b - short term 9.13b)
Short Term Debt = 9.13b USD (from shortTermDebt, last quarter)
Debt = 104.58b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 74.36b USD (from netDebt column, last quarter)
Enterprise Value = 303.94b USD (229.58b + Debt 104.58b - CCE 30.22b)
Interest Coverage Ratio = 6.98 (Ebit TTM 32.56b / Interest Expense TTM 4.66b)
EV/FCF = 13.38x (Enterprise Value 303.94b / FCF TTM 22.71b)
FCF Yield = 7.47% (FCF TTM 22.71b / Enterprise Value 303.94b)
FCF Margin = 8.53% (FCF TTM 22.71b / Revenue TTM 266.38b)
Net Margin = 6.68% (Net Income TTM 17.80b / Revenue TTM 266.38b)
Gross Margin = 16.43% ((Revenue TTM 266.38b - Cost of Revenue TTM 222.61b) / Revenue TTM)
Gross Margin QoQ = 15.63% (prev 16.73%)
Tobins Q-Ratio = 0.82 (Enterprise Value 303.94b / Total Assets 370.35b)
Interest Expense / Debt = 1.14% (Interest Expense 1.19b / Debt 104.58b)
Taxrate = 39.40% (2.71b / 6.89b)
NOPAT = 19.73b (EBIT 32.56b * (1 - 39.40%))
Current Ratio = 1.30 (Total Current Assets 107.17b / Total Current Liabilities 82.42b)
Debt / Equity = 0.60 (Debt 104.58b / totalStockholderEquity, last quarter 174.39b)
Debt / EBITDA = 1.36 (Net Debt 74.36b / EBITDA 54.69b)
Debt / FCF = 3.27 (Net Debt 74.36b / FCF TTM 22.71b)
Total Stockholder Equity = 177.54b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.70% (Net Income 17.80b / Total Assets 370.35b)
RoE = 10.03% (Net Income TTM 17.80b / Total Stockholder Equity 177.54b)
RoCE = 11.93% (EBIT 32.56b / Capital Employed (Equity 177.54b + L.T.Debt 95.45b))
RoIC = 11.05% (NOPAT 19.73b / Invested Capital 178.59b)
WACC = 5.11% (E(229.58b)/V(334.15b) * Re(7.12%) + D(104.58b)/V(334.15b) * Rd(1.14%) * (1-Tc(0.39)))
Discount Rate = 7.12% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -6.48%
[DCF] Terminal Value 85.15% ; FCFF base≈27.66b ; Y1≈24.76b ; Y5≈21.00b
[DCF] Fair Price = 199.0 (EV 635.06b - Net Debt 74.36b = Equity 560.70b / Shares 2.82b; r=5.90% [WACC]; 5y FCF grow -12.96% → 2.90% )
EPS Correlation: -53.07 | EPS CAGR: -18.01% | SUE: -0.53 | # QB: 0
Revenue Correlation: -89.29 | Revenue CAGR: -7.05% | SUE: -0.13 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.56 | Chg7d=-0.030 | Chg30d=-0.002 | Revisions Net=-2 | Analysts=6
EPS current Year (2026-12-31): EPS=6.09 | Chg7d=+0.005 | Chg30d=-0.360 | Revisions Net=-1 | Growth EPS=-3.4% | Growth Revenue=-2.5%
EPS next Year (2027-12-31): EPS=7.11 | Chg7d=+0.011 | Chg30d=-0.431 | Revisions Net=-7 | Growth EPS=+16.8% | Growth Revenue=+8.8%
[Analyst] Revisions Ratio: -0.33 (2 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.6% (Discount Rate 7.9% - Earnings Yield 7.4%)
[Growth] Growth Spread = +3.1% (Analyst 3.7% - Implied 0.6%)
P/E Forward = 10.7875
P/S = 0.8602
P/B = 1.1445
P/EG = 1.6278
Revenue TTM = 266.38b USD
EBIT TTM = 32.56b USD
EBITDA TTM = 54.69b USD
Long Term Debt = 95.45b USD (estimated: total debt 104.58b - short term 9.13b)
Short Term Debt = 9.13b USD (from shortTermDebt, last quarter)
Debt = 104.58b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 74.36b USD (from netDebt column, last quarter)
Enterprise Value = 303.94b USD (229.58b + Debt 104.58b - CCE 30.22b)
Interest Coverage Ratio = 6.98 (Ebit TTM 32.56b / Interest Expense TTM 4.66b)
EV/FCF = 13.38x (Enterprise Value 303.94b / FCF TTM 22.71b)
FCF Yield = 7.47% (FCF TTM 22.71b / Enterprise Value 303.94b)
FCF Margin = 8.53% (FCF TTM 22.71b / Revenue TTM 266.38b)
Net Margin = 6.68% (Net Income TTM 17.80b / Revenue TTM 266.38b)
Gross Margin = 16.43% ((Revenue TTM 266.38b - Cost of Revenue TTM 222.61b) / Revenue TTM)
Gross Margin QoQ = 15.63% (prev 16.73%)
Tobins Q-Ratio = 0.82 (Enterprise Value 303.94b / Total Assets 370.35b)
Interest Expense / Debt = 1.14% (Interest Expense 1.19b / Debt 104.58b)
Taxrate = 39.40% (2.71b / 6.89b)
NOPAT = 19.73b (EBIT 32.56b * (1 - 39.40%))
Current Ratio = 1.30 (Total Current Assets 107.17b / Total Current Liabilities 82.42b)
Debt / Equity = 0.60 (Debt 104.58b / totalStockholderEquity, last quarter 174.39b)
Debt / EBITDA = 1.36 (Net Debt 74.36b / EBITDA 54.69b)
Debt / FCF = 3.27 (Net Debt 74.36b / FCF TTM 22.71b)
Total Stockholder Equity = 177.54b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.70% (Net Income 17.80b / Total Assets 370.35b)
RoE = 10.03% (Net Income TTM 17.80b / Total Stockholder Equity 177.54b)
RoCE = 11.93% (EBIT 32.56b / Capital Employed (Equity 177.54b + L.T.Debt 95.45b))
RoIC = 11.05% (NOPAT 19.73b / Invested Capital 178.59b)
WACC = 5.11% (E(229.58b)/V(334.15b) * Re(7.12%) + D(104.58b)/V(334.15b) * Rd(1.14%) * (1-Tc(0.39)))
Discount Rate = 7.12% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -6.48%
[DCF] Terminal Value 85.15% ; FCFF base≈27.66b ; Y1≈24.76b ; Y5≈21.00b
[DCF] Fair Price = 199.0 (EV 635.06b - Net Debt 74.36b = Equity 560.70b / Shares 2.82b; r=5.90% [WACC]; 5y FCF grow -12.96% → 2.90% )
EPS Correlation: -53.07 | EPS CAGR: -18.01% | SUE: -0.53 | # QB: 0
Revenue Correlation: -89.29 | Revenue CAGR: -7.05% | SUE: -0.13 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.56 | Chg7d=-0.030 | Chg30d=-0.002 | Revisions Net=-2 | Analysts=6
EPS current Year (2026-12-31): EPS=6.09 | Chg7d=+0.005 | Chg30d=-0.360 | Revisions Net=-1 | Growth EPS=-3.4% | Growth Revenue=-2.5%
EPS next Year (2027-12-31): EPS=7.11 | Chg7d=+0.011 | Chg30d=-0.431 | Revisions Net=-7 | Growth EPS=+16.8% | Growth Revenue=+8.8%
[Analyst] Revisions Ratio: -0.33 (2 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.6% (Discount Rate 7.9% - Earnings Yield 7.4%)
[Growth] Growth Spread = +3.1% (Analyst 3.7% - Implied 0.6%)